Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014306HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30014330HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30010713HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30007991HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30010714HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30007992HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30015925HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30015924HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30012871HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30012872HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TCGA Plot Options
Drug Information
GeneTOP1
DrugBank IDDB06159
Drug NameRubitecan
Target IDBE0000971
UniProt IDP11387
Regulation Type
PubMed IDs16193332
CitationsChedid S, Rivera E, Frye DK, Ibrahim N, Esteva F, Valero V, Hortobagyi G, Mettinger KL, Cristofanilli M: Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer. Cancer Chemother Pharmacol. 2006 Apr;57(4):540-4. Epub 2005 Sep 29.
GroupsInvestigational
Direct Classification
SMILESCC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O
Pathways
PharmGKB
ChEMBLCHEMBL77305